Integrative Treatment Methods in COVID-19

NCT05089578 | Completed

• 1 other identifier: Amasya U-2
• Study Type: observational
• Target: 12
• Locations: 1 country
• Sites: 1

Brief Summary

This study was conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. In this study, which was designed in the qualitative and phenomenological type, the criterion sampling method was used and 12 people were included in the sample.

Conditions

COVID-19; Patient Experience; Health Attitude

Keywords

Covid-19; patient experince; integrative treatment; qualitative study; health promotion model

Outcome Measures

Primary Outcomes (2)

• Using integrative treatment method

  All participants included in the study had used at least one of the integrative treatment methods.

  15 July- October 2021

• Kind of integrative treatment methods

  It was determined that vitamin C and medicinal plants were frequently used in addition to their medical treatments.

  October 2021

Study Arms (1)

Individuals with Covid-19

Interviews were conducted with individuals who had Covid-19, and their experiences with the integrative methods they used were determined.

Other: focus interview

Interventions

focus interview OTHER

The "Information Form" including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured "Interview Form", and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.

Individuals with Covid-19

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Individuals who underwent Covid-19 and used any of the integrative treatment methods constituted the population of the study. Using the criterion sampling method, individuals who underwent Covid-19 and used any of the integrative treatment methods and agreed to participate in the study constituted the sample group. In accordance with the nature of qualitative research, the study was completed with 12 people.

You may qualify if:

• individuals who underwent Covid-19 and used any of the integrative treatment methods
• agreed to participate in the study constituted the sample group.

Sponsors & Collaborators

• Amasya University: lead

Study Sites (1)

Amasya University Sciences Faculty

Amasya, 05100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Gamze Fıskın, PhD

  Amasya University

  PRINCIPAL INVESTIGATOR

• Nurhan Dogan, PhD

  Amasya University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Asisst.Prof.

Study Record Dates

• First Submitted: October 20, 2021
• First Posted: October 22, 2021
• Study Start: July 15, 2021
• Primary Completion: October 15, 2021
• Study Completion: October 15, 2021
• Last Updated: October 22, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)